Global Immunotherapy Drugs Market

Dec 2018| VMR506A| Verified Market Research

Report Highlights

Market Overview:
The global Immunotherapy Drugs market was valued at USD 108.39 billion in 2016 and is projected to reach USD 338.54 billion by 2025, growing at a CAGR of 13.49% from 2017 to 2025.

Immunotherapy is in high demand due to increased preference for minimal invasive treatment methods and advantages provided by the treatment type. The market is expected to grow during the forecast period.

Market Dynamics:
1. Market Drivers
1.1 Increasing Adoption of Targeted Therapy
1.2 Emergence of Biosimilars
1.3 Increasing Demand for Mabs
1.4 High Prevalence Rate of Lifestyle Diseases
1.5 Fast Track and Orphan Drug Designations
2. Market Restraints
2.1 High Cost of Immunotherapy Treatment
2.2 High Attrition Rate in the Product Development Cycle

Market Segmentation:
1. By Therapy Area:
1.1 Cancer
1.2 Autoimmune and Inflammatory Diseases
1.3 Infectious Diseases
1.4 Other Therapy Areas

2. By End User:
2.1 Hospitals
2.2 Clinics
2.3 Other End Users

3. By Type of Drug:
3.1 Monoclonal Antibodies
3.2 Adult Vaccines
3.2.1 Preventive Vaccines
3.2.2 Therapeutic Vaccines
3.3 Checkpoint Inhibitors
3.4 Interferons Alpha & Beta
3.5 Interleukins
3.6 Other Drugs

4. By Region:
4.1 North America (U.S., Canada, Mexico)
4.2 Europe (Germany, UK, France, Rest of Europe)
4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
4.4 Latin America (Brazil, Argentina, Rest of Latin America)
4.5 Middle East & Africa

Competitive Landscape:
The major players in the market are as follows:
1. F. Hoffmann-La Roche AG
2. Merck & Co., Inc.
3. Novartis International AG
4. Johnson & Johnson (A Parent Company of Janssen Biotech, Inc.)
5. Glaxosmithkline PLC
6. Amgen Inc.
7. Abbvie
8. Astrazeneca
9. Bristol-Myers Squibb
10. ELI Lilly and Company
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Immunotherapy Drugsmarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.

To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.

Verified Market Research has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. It has large database which includes the latest content from renowned authors and publications worldwide. It also provides customized Data and Reports according to the need of the client.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report